Feghali-Bostwick Lab retweeted
BREAKING: The federal funding bill that is apparently close to becoming law would slash more than $1 billion from DoD health research, including cutting in half the money for a program that experts tell me has produced life-saving treatments.
rollcall.com/2025/03/13/fear…
Feghali-Bostwick Lab retweeted
#NIH in jeopardy: science.org/content/article/…
Feghali-Bostwick Lab retweeted
In observation of Scleroderma Awareness Month, we're re-sharing a past episode of Science Never Sleeps featuring Carol Feghali-Bostwick, PhD, discussing scleroderma, fibrosis & research to find treatments & possible cures. Listen on Spotify or at the link! bit.ly/3Vxl1ns
Feghali-Bostwick Lab retweeted
We are excited to announce that images are now available from #NAI2024! Newly inducted Fellows and Senior Members can find their images in our online gallery here: ow.ly/MJN250SlH15
#innovation #invention
Feghali-Bostwick Lab retweeted
It was fantastic to hear from leading women in #STEM on how they’ve evolved as innovators and how they’re leveraging intellectual property protection during the @uspto Women in Entrepreneurship Panel at #NAI2024, moderated by NAI Executive Director Jamie Renee, HonNAI!
Amazing ceremony and evening! So fortunate to be elected fellow of the National Academy of Inventors! Still seems surreal!
Feghali-Bostwick Lab retweeted
We're joining @NIHdpc & @EnhanceScience to show the #faceofscience featuring members of our CREW program! CREW is an NIH-supported coaching program that helps female researchers & faculty prepare for future entrepreneurial efforts. Learn more here: rb.gy/7k6grj
Very honored to be elected as Fellow of the National Academy of Inventors!
The National Academy of Inventors is proud to announce the Fellows Class of 2023!
The new class is comprised of 162 prolific academic innovators from over 115 research universities and research institutes worldwide.
View the Fellows Class of 2023: bit.ly/3RmAHYM
3
8
417
Feghali-Bostwick Lab retweeted
The National Academy of Inventors is proud to announce the Fellows Class of 2023!
The new class is comprised of 162 prolific academic innovators from over 115 research universities and research institutes worldwide.
View the Fellows Class of 2023: bit.ly/3RmAHYM
Extracellular vesicles could aid spread of sc | EurekAlert! eurekalert.org/news-releases…
Feghali-Bostwick Lab retweeted
Excited to share our newest findings implicating extracellular vesicles in the propagation of lung #fibrosis in #SystemicSclerosis!
@ResearchMUSC @musc_cgs @FeghaliLab
onlinelibrary.wiley.com/doi/…
Extracellular Vesicles Propagate Lung Fibrosis in Systemic Sclerosis.
Excited to share our most recent publication! onlinelibrary.wiley.com/doi/…
Feghali-Bostwick Lab retweeted
‘The #tipping #point is coming’: Concern about an unprecedented #exodus of young life #scientists is shaking up academia statnews.com/2022/11/10/tipp…
Very honored and humbled to receive this award! eurekalert.org/news-releases…
2
12
1,341
Our most recent publication: First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry mdpi.com/1422-0067/24/4/3645
Feghali-Bostwick Lab retweeted
Most research on scleroderma, a connective tissue disease that causes scarring, or fibrosis, has focused on the increased number of proteins promoting fibrosis. MUSC researchers report that these patients also have reduced levels of antifibrotic proteins. https://nitter.cf/t.co/cIDOpbMAeq
Feghali-Bostwick Lab retweeted
Reversing #lungfibrosis in #scleroderma requires an increase in antifibrotic proteins @MUSCHealth doi.org/gqw2zb medicalxpress.com/news/2022-…



















